Cyclobenzaprine SR Pellets Manufacturer in India

Cyclobenzaprine SR Pellets (CAS No: 6202-23-9)

Pharmaceutical-Grade Sustained Release Pellets for Oral Dosage Forms

Cyclobenzaprine SR Pellets are pharmaceutical-grade sustained-release multiparticulate pellets containing Cyclobenzaprine Hydrochloride, designed for controlled-release oral dosage-form applications. These pellets are suitable for pharmaceutical formulation development, capsule filling and other multiparticulate oral dosage forms requiring a sustained drug-release profile. Cyclobenzaprine Hydrochloride has the molecular formula C₂₀H₂₂ClN and a molecular weight of approximately 311.8 g/mol.

Cyclobenzaprine sustained-release pellets can be manufactured using drug-layering and functional polymer-coating technologies to achieve the required release characteristics. Published formulation research has described Cyclobenzaprine Hydrochloride sustained-release pellets using drug coating followed by polymer coating and evaluation of the resulting in-vitro drug-release profile.

Key Features

• Cyclobenzaprine Hydrochloride sustained-release multiparticulate formulation
• Designed for controlled and sustained drug-release applications
• Suitable for pharmaceutical capsule filling and oral dosage-form development
• Flexible formulation platform for defined drug loading and dissolution requirements
• Suitable for modified-release pharmaceutical formulations
• Product-specific pellet size, drug loading and release characteristics
• Appropriate for bulk pharmaceutical formulation applications

Applications

• Hard gelatin capsule filling for sustained-release oral dosage forms
• Multiparticulate oral dosage-form manufacturing
• Modified-release pharmaceutical formulations
• Sustained-release capsule formulations
• Pharmaceutical formulation development
• Drug-loaded pellet applications
• Bulk pharmaceutical pellet supply
• Oral solid dosage-form development

Why Choose Cyclobenzaprine SR Pellets?

• Sustained-release multiparticulate platform for Cyclobenzaprine Hydrochloride
• Designed for controlled drug-release formulation requirements
• Suitable for capsule-based multiparticulate dosage forms
• Flexible drug loading and release-profile options, subject to product specification
• Suitable for pharmaceutical formulation and development applications
• Quality evaluation can include identification, assay/drug content, related substances, moisture and dissolution testing
• Available formulation characteristics can be established according to customer and product requirements

Packaging & Supply

Cyclobenzaprine SR Pellets can be supplied in suitable pharmaceutical packaging for formulation development and bulk manufacturing applications. Packaging configuration, drug loading, pellet characteristics, release profile, quantity and storage requirements should be confirmed according to the applicable product specification and customer requirements.

Get Bulk Quote via WhatsApp